Fox Chase Cancer Center News

CHICAGO, IL (May 29, 2013)—A new study by Fox Chase Cancer Center researchers—which will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology on Monday, June 3—has identified a disconnect between clinical trials that look at new treatments for metastatic pancreatic cancer and the patient population most likely to be diagnosed with the disease. Clinical trials typically enroll, and base their findings on, patients in their 50's and 60's, but the median age at diagnosis is 72.

CHICAGO, IL (May 29, 2013)—A promising new therapy for the most common form of lung cancer appears to produce largely manageable side effects, and an ongoing clinical trial is determining whether the compound treats tumors more effectively than what's on the market, according research that scientists at Fox Chase Cancer Center will present at the 49th Annual Meeting of the American Society of Clinical Oncology on Saturday, June 1.

CHICAGO, IL (May 29, 2013)—Nearly two-thirds of solid tumors carry at least one mutation that may be targeted, or medicated, by an existing compound, according to new findings from researchers Fox Chase Cancer Center that will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology on June 3. The results suggest that it may one day become commonplace for doctors to sequence tumors before deciding on a treatment regimen.

PHILADELPHIA (May 20, 2013)—Fox Chase Cancer Center recently honored Margaret Foti, PhD, MD (hc), CEO of the American Association for Cancer Research (AACR), with the 2013 Stanley P. Reimann Honor Award for her significant contributions to cancer science and medicine.

PHILADELPHIA, PA (May 8, 2013)—Fox Chase Cancer Center will be hosting a Cancer Conversations LIVE event featuring author Jessica Wapner on Tuesday, May 14 at 7:00 p.m. in the Fox Chase Auditorium (Center Building, 333 Cottman Aveue, Philadelphia). At the event, Jessica will discuss her new book The Philadelphia Chromosome: a Mutant Gene and the Quest to Cure Cancer at the Genetic Level—just published this spring.

(Philadelphia, PA, April 30, 2013) – Sixty (60) Temple physicians have been named to Philadelphia magazine’s annual “Top Doctors” list. Nominated by their professional peers, the physicians on the list practice at Temple University Hospital, Fox Chase Cancer Center and Jeanes Hospital.

PHILADELPHIA, PA (April 17, 2013)—Join the Eileen Stein Jacoby Fund as they host the 4th Annual FitLife Marathon for a Cure on Sunday, April 21 from 1:00-5:00 p.m. at the FitLife Performance Center in Ivyland, PA (157 Railroad Drive). Every year the event brings together high school and college students from Philadelphia, Montgomery and Bucks County to participate in a variety of fitness activities—running, fitness training, relays, tag and more—to help raise funds for breast cancer research at Fox Chase Cancer Center.

WASHINGTON, DC (April 10, 2013)—A common virus known to cause cervical and head and neck cancers may also trigger some cases of lung cancer, according to new research presented by Fox Chase Cancer Center at the AACR Annual Meeting 2013 on Wednesday, April 10.

Examining tissue samples from lung cancer patients, the researchers found that nearly 6% showed signs they may have been driven by a strain of human papillomavirus (HPV) known to cause cancer.